Home News Startups, Entrepreneurs, Digital economy

Engine Biosciences secures US$10 mil of seed capital from US & Asian investors

Michelle Zhu
Michelle Zhu1/31/2018 07:00 PM GMT+08  • 3 min read
Engine Biosciences secures US$10 mil of seed capital from US & Asian investors
SINGAPORE (Jan 31): A biotech company with offices in Singapore and San Francisco, Engine Biosciences, says it has secured US$10 million ($13.1 million) in seed funding from both American and Asian investors.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

SINGAPORE (Jan 31): A biotech company with offices in Singapore and San Francisco, Engine Biosciences, says it has secured US$10 million ($13.1 million) in seed funding from both American and Asian investors.

The heavily-oversubscribed seed round makes it the largest seed financing recorded in Southeast Asia, and one of the largest in Asia in the tech and biotech industries, according to Engine.

It was co-led by Silicon Valley’s Danhua Capital (DHVC) and 6 Dimensions Capital, a healthcare investment group formed through the merger of Frontline Bioventures and Wuxi Healthcare Ventures.

×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.